CRISPR Therapeutics AG

34.20
1.06 (3.20%)
At close: Apr 02, 2025, 3:59 PM
32.17
-5.94%
Pre-market: Apr 03, 2025, 04:00 AM EDT

CRISPR Therapeutics AG Revenue

CRISPR Therapeutics AG reported an annual revenue of $35M, reflecting a -90.57% growth. For the quarter ending December 31, 2024, CRISPR Therapeutics AG generated $35M in revenue.
Revenue (ttm)
$35M
Revenue Growth
-90.57%
Price / Sales Ratio
94.87
Revenue / Employee
$89.06K
Employees
393
Market Cap
2.93B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 35M -90.57%
Dec 31, 2023 371.21M +85038.99%
Dec 31, 2022 436K -99.95%
Dec 31, 2021 913.08M +168054.88%
Dec 31, 2020 543K n/a